Award-Recognized Science. Results You Can Feel.
2026 INNOCOS Beauty & Longevity CHOICE Awards Finalist
2026 INNOCOS Beauty & Longevity CHOICE Awards Finalist
The INNOCOS Beauty, Tech & Longevity Summit named our Total NAD+ Restoration Protocol and Renue Blue Face Serum as finalists for the 2026 Beauty & Longevity CHOICE Awards.
The INNOCOS summit is where researchers, investors, and industry leaders decide what's moving longevity science forward, and our formulas are contenders for the top spot.
Everyone in supplements claims "science-backed."
Being an INNOCOS finalist means our approach passed scrutiny from people who know the difference between marketing and mechanisms.
The nomination validates something we've been saying for a while now: single-ingredient approaches leave most of the benefit on the table. The Four Pathways model exists because NAD+ biology doesn't work in isolation.
Most NAD+ supplements throw a precursor at the problem and call it a day.
That's like filling a bucket with holes in it.
What’s happening at the cellular level is a deeper story: NAD+ consuming enzymes increase with age and inflammation, draining NAD+ faster than most people can replenish it. Mitochondrial inefficiency wastes what's left. Accumulated cellular damage creates constant repair demand. Taking more NMN doesn't solve a systems problem.
Four pathways, four targeted formulas, working together synergistically. This systems-level approach promotes the kind of healthy NAD+ levels that single-target solutions can’t match.
Your skin cells face the same NAD+ decline as the rest of your body.
Fine lines, loss of firmness, uneven tone: these reflect what's happening at the cellular level.
We use the same philosophy in our skincare as our supplements: liposomal delivery methods tailored to absorption mechanisms to optimize bioavailability and results.
Moisturization, barrier protection, and short-term effects aren’t enough. The unique ingredients in our Serum promote skin becoming smoother and more radiant over time, validating our approach to beauty through genuine cellular health.
The longevity space is crowded with "revolutionary" claims. INNOCOS cuts through that noise by asking a simple question: does the science hold up?
Their panel includes researchers who publish the studies, investors who stake their capital on outcomes, and clinicians who see what actually works in practice.
They believe this is the direction the industry should be moving.
NAD+ isn't a vitamin. It's a coenzyme that shuttles electrons between reactions in every cell. When levels drop, the traffic slows. Mitochondria produce less ATP. Sirtuins can't do their repair work. DNA damage accumulates because PARP enzymes can't access enough NAD+ to fix it.
This feels like decreased daily energy, slower thinking, and feeling like less of yourself. You start cancelling plans, shortening workouts, and waking up without feeling like you slept.
Most supplements address one piece. We address the system: supply multiple precursors, inhibit the enzymes draining your pool, support how efficiently your mitochondria use what you have, and promote the overnight cleanup that reduces tomorrow's demand.
Transparent formulation has been our standard from the beginning. Published certificates of analysis. Third-party testing on every batch. Dosing decisions driven by research, not margin targets.
None of this is new for us. The INNOCOS nomination validates an approach we've held for years, and we’ll keep making innovative science accessible to the longevity community.
2026 INNOCOS Beauty & Longevity CHOICE Awards Finalist
Awards Ceremony: February 19th • Silicon Valley
Questions? Email support@renuebyscience.com